Navellier & Associates Inc Clear Point Neuro, Inc. Transaction History
Navellier & Associates Inc
- $839 Million
- Q2 2024
A detailed history of Navellier & Associates Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Navellier & Associates Inc holds 50,000 shares of CLPT stock, worth $559,500. This represents 0.03% of its overall portfolio holdings.
Number of Shares
50,000
Previous 50,000
-0.0%
Holding current value
$559,500
Previous $340,000
20.88%
% of portfolio
0.03%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
90Shares Held
7.04MCall Options Held
35KPut Options Held
22.8K-
Vanguard Group Inc Valley Forge, PA1.22MShares$13.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny465KShares$5.21 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA463KShares$5.18 Million0.49% of portfolio
-
Taylor Frigon Capital Management LLC425KShares$4.75 Million1.1% of portfolio
-
Cm Management, LLC375KShares$4.2 Million1.88% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $274M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...